Determinants of Ultra-Long-Term Survival in Multiple Myeloma: A Critical Appraisal of Foundational Assumptions and a Call for Biologically Driven Inquiry [0.03%]
评估多发性骨髓瘤特长期生存影响因素及生物驱动研究的现状和未来方向——对基础假设的重要再评价
DuJiang Yang,Jiexiang Yang,Shuang Wang et al.
DuJiang Yang et al.
Trends in GVHD Epidemiology, Prophylaxis and Management: The Gruppo Italiano per il Trapianto di Midollo Osseo, Cellule Staminali Emopoietiche e Terapia Cellulare (GITMO) GVHD24 Study [0.03%]
GVHD的流行病学、预防和管理趋势：来自意大利骨髓移植、造血干细胞移植及细胞治疗协会（GITMO）的GVHD24研究
Nicola Polverelli,Caterina Zerbi,Maria Grazia Benevento et al.
Nicola Polverelli et al.
Compared to historical reports, both aGVHD and cGVHD appeared to have decreased in the recent transplant era, possibly due to the extension of T-cell depletion, the availability of effective second-line approaches in SR/D GVHD and improved ...
Effectiveness of Gilteritinib Beyond Second-Line Therapy in Relapsed/Refractory FLT3-Mutated Acute Myeloid Leukemia: A Real-World Multicenter Study of 171 Patients [0.03%]
一项针对171例患者的现实世界多中心研究：在二线治疗后吉列替尼对复发/难治FLT3突变急性髓系白血病的有效性
Matteo Molica,Gema Miralles,Richard Dillon et al.
Matteo Molica et al.
Gilteritinib is a selective FLT3 inhibitor approved for the treatment of relapsed or refractory (R/R) FLT3-mutated acute myeloid leukemia (AML) following ≥ 1 prior line of therapy. However, data on its effectiveness in later-line settings ...
Advancing Anemia Detection With Deep Neural Networks: A Comparative Analysis of Training Strategies Using Conjunctival Images [0.03%]
基于深度神经网络的眼结膜图像检测贫血的训练策略比较分析
Parsa Riazi Esfahani,Tri Brian Nguyen,Akshay Reddy et al.
Parsa Riazi Esfahani et al.
Daratumumab in Pediatric Chronic Refractory Primary Immune Thrombocytopenia (ITP): Rapid Platelet Recovery, Sustained Response, and Immune Reconstitution Dynamics [0.03%]
达雷妥尤单抗治疗儿童慢性难治性原发免疫性血小板减少症（ITP）：快速的血小板恢复、持续应答和免疫重建动力学
Yu Hu,Hui Chen,Zhifa Wang et al.
Yu Hu et al.
Polygenic Variation Underlying Neutrophil Counts Modifies the Penetrance of Duffy-Null Neutropenia [0.03%]
多基因变异影响Duffy阴性中性粒细胞减少症的外显率
John P Shelley,Mingjian Shi,Lisa Bastarache et al.
John P Shelley et al.
DNA Methylation Episignature as a Novel Diagnostic Tool for Diamond-Blackfan Anemia Syndrome [0.03%]
DNA甲基化表观标志物可作为钻石-布莱克芬贫血症的新诊断工具
Paola Quarello,Karim Karimi,Slavica Trajkova et al.
Paola Quarello et al.
Diamond-Blackfan Anemia Syndrome (DBAS) is a rare inherited bone marrow failure syndrome (IBMFS) characterized by impaired erythropoiesis and significant genetic heterogeneity. Diagnosis can be challenging due to clinical variability and th...
Recurrent Thrombocytopenia During Caplacizumab Therapy in Acute Immune-Mediated Thrombotic Thrombocytopenic Purpura [0.03%]
卡普拉朱单抗治疗急性免疫性血栓性血小板减少性紫癜复发性血小板减少症病例报告
Kenki Saito,Kazuya Sakai,Atsushi Hamamura et al.
Kenki Saito et al.